Natac Natural Ingredients SA
BBME:NAT0.57
EUR
-0.01
(-2.56%)
ISIN
ES0171613005
Return %
Stock
S&P 500
1Y
-32.54
14.39
3Y
-42.94
81.42
5Y
-42.94
68.62
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Semi-annual Revenue
EUR
•
in mil. unless spec.Semi-annual Earnings Per Share
EUR
•
in mil. unless spec.Semi-annual Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- CEO
- Antonio Angel Delgado Romero
- Full Time Employees
- 181
- Sector
- Finance
- Industry
- Real estate investment trusts
- Address
- Avenida Rita Levi Montalcini 14 Madrid MA Spain 28906
- IPO Date
- Dec 4, 2013
- Website
- iffefutura.es
- Similar Companies
- Business
- Iffe Futura, S.A., now operating under the name Natac Natural Ingredients, S.A., is a Spain-based company specializing in the research, development, production, and marketing of natural ingredients focused primarily on plant extracts and Omega-3 oils. The company’s core product portfolio includes sustainable botanical extracts and high-quality Omega-3 fatty acids, which serve diverse sectors such as functional foods, nutritional supplements, pharmaceuticals, cosmetics, and animal nutrition. Founded and headquartered in Oleiros, La Coruña, Spain, Iffe Futura has positioned itself as a leading operator in natural ingredients with advanced development and refinement capabilities, particularly emphasizing innovative plant-derived and marine-based active compounds. In a major strategic development in 2023, Iffe Futura completed a reverse merger with Natac, creating a larger group that synergistically combines the strengths of both entities. This merger expanded their portfolio and geographic presence, consolidating research and production facilities including sites in Córdoba and Hervás for plant extracts and in As Somozas, Galicia, for Omega-3 production. Recently, the company secured €18 million financing led by Inveready and attracted strategic partnerships including NATAC Group as a minority shareholder in its Omega-3 production subsidiary, IFFE BIOTECH, bolstering capacity and market reach. Additionally, in late 2025, Iffe Futura signed a €20 million equity commitment with LDA Capital to support its strategic growth plan amid challenging market conditions. Iffe Futura operates primarily through two divisions: Plant Extracts, focused on developing a broad range of natural extracts from botanicals with proven health benefits; and Omega-3, dedicated to manufacturing premium quality Omega-3 oils with a production capacity exceeding 10,000 tons per year at its Galicia facility. The company has a dedicated R&D focus on sustainable, industrially viable projects that leverage scientific knowledge to create high-performance ingredients. Its products target B2B markets including functional food companies and pharmaceutical industries across Spain and broader European markets, aiming to capitalize on growing demand for natural and health-enhancing ingredients. The company remains listed on BME Growth, with its evolution marked by continuous innovation in natural ingredient production and strategic financial partnerships that underpin its expansion. The merger with Natac and subsequent investments have positioned Natac Natural Ingredients as a significant player in the European natural extracts and Omega-3 oil markets, focusing on sustainability, quality, and industrial viability. This strategic expansion reflects a broader trend towards health-oriented natural product solutions with robust research, production, and marketing capabilities across several countries in Europe.